comparemela.com
Home
Live Updates
Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS : comparemela.com
Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing funding specifically in the Development of KLS-13019 for Neuropathic
Related Keywords
United States ,
American ,
Kostenloser Wertpapierhandel ,
Kathryn Brown ,
Louie Toma ,
Neuropathix Inc ,
Pennsylvania Biotechnology Center ,
National Institutes Of Health ,
Drug Administration ,
Company Twitter ,
Initiative Helping End Addiction ,
Pfizer ,
Securities Exchange ,
National Institute ,
Helping End Addiction Long Term ,
Dean Petkanas ,
National Institutes ,
Bucks County ,
Securities Act ,
Securities Exchange Act ,
Safe Harbor ,
United States Controlled Substances ,
Neuropathix ,
Highlights ,
Revenue ,
Elated ,
Rant ,
Award ,
Kinds ,
comparemela.com © 2020. All Rights Reserved.